Exceeding 30 ELNs is strongly recommended for pT3‐4N0 patients with gastric cancer: A multicenter study of survival, recurrence, and prediction modelLulu Zhao, Yingtai Chen, Xiaojie Zhang et al.|Cancer Science|2021Cited by 20
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational studyXianchun Gao, Lulu Zhao, Nannan Zhang et al.|International Journal of Surgery|2023Cited by 15
Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort studyXianchun Gao, Yongzhan Nie, Gang Li et al.|The Lancet Regional Health - Western Pacific|2024Cited by 9
Impact of the HER2 Expression on Survival and Fluorouracil-Based Adjuvant Chemotherapeutic Benefits in Stage II/III Gastric Cancer: A Multicenter Observational StudyXianchun Gao, MAGIS Study Group, Lulu Zhao et al.|SSRN Electronic Journal|2022Cited by 0